Suraksha Diagnostic Ltd (SURAKSHA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Suraksha Diagnostic Ltd on NSE and BSE, with an AI summary of each filing.
Intimation regarding change in the Corporate Office of Registrar to an issue and Share Transfer Agent(RTA) of the Company with effect from 01 December, 2026
Others (Uncategorized) · 04 Nov 2026, 12:21 am
Suraksha Diagnostic: Corporate Office Relocation of RTA KFin Technologies Suraksha Diagnostic Limited has informed stock exchanges that its Registrar to an Issue and Share Transfer Agent (RTA), KFin Technologies Limited, will shift its Corporate Office to Rajapushpa West Avenue, Kokapet, Hyderabad (Telangana - 500075), effective 1st Dec'26. The RTA's Registered Office remains unchanged. All future corporate and investor communications concerning the RTA's corporate office will be routed through the new location.
The Board was aprised that the Company had received a notice dated 31-08-2026 from NSE, intimating that Company of non-Compliance with Regulation 31 of SEBI(LODR) Regulation 2015. The same ....
Others (Uncategorized) · 14 Oct 2026, 11:06 pm
Suraksha Diagnostic Settles NSE Penalty Over Delayed Shareholding Pattern Filing Suraksha Diagnostic's Board reviewed an NSE notice dated 31st Aug'26 concerning non-compliance with Regulation 31 of SEBI LODR Regulations due to a one-day delay in submitting its shareholding pattern for the quarter ended 30th Jun'26. The exchange levied a fine of Rs. 2,360 (including GST), which the company paid on 29th Sep'26. The Board directed the secretarial team to tighten internal compliance monitoring to prevent recurrence, confirming no material impact on operations or financials.
Appointment of Ms. Shreya Arora as Company Secretary & Compliance Officer of the Company
Change in Management · 14 Oct 2026, 10:58 pm
Suraksha Diagnostic Appoints Shreya Arora as Company Secretary and Compliance Officer Suraksha Diagnostic Limited approved the appointment of Ms. Shreya Arora as Company Secretary and Compliance Officer, effective 14th Oct'26, following the recommendation of the Nomination and Remuneration Committee. Arora brings over 12 years of experience in corporate secretarial functions, legal affairs, and regulatory compliance, having previously served as Company Secretary and Legal Head at Kutchina Home Makers Private Limited. Additionally, the Board reviewed comments regarding the delay in filing the company's shareholding pattern with the National Stock Exchange of India.
Voting Results & Scrutinizer''s Report for the 21st Annual General Meeting (AGM) of the Company held on 22nd September, 2026
Annual General Meeting · 24 Sept 2026, 9:24 pm
Revised Proceedings of the 21st Annual General Meeting (AGM) of the Company
Annual General Meeting · 23 Sept 2026, 9:38 pm
Proceedings of the 21st Annual General Meeting of the Company held on 22nd September, 2026.
Annual General Meeting · 22 Sept 2026, 11:57 pm
Please find enclosed the letter sent to those shareholders whose e-mail address are not registered, providing the web link of the Company''s website from where Annual Report for the Financial ....
Annual Report · 28 Aug 2026, 1:18 am
Please find enclosed the Notice of 21st Annual General Meeting of the Company scheduled to be held on 22nd September, 2026
Annual General Meeting · 28 Aug 2026, 1:09 am
Please find enclosed the Annual Report of the Company for the financial year 2025-26, including Notice dated 12th August, 2026 convening the 21st Annual General Meeting (AGM) of the Company ....
Others (Uncategorized) · 28 Aug 2026, 1:05 am
The text Transcript of Earning call held on 13 August 2026 at 11:30 a.m. (IST)with respect to the unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter ....
Transcript · 17 Aug 2026, 9:55 pm
Intimation of outcome of audio recording of analyst/Institutional Investor/Organizations meet-"Earning Call" which was held today i.e. 13 August 2026
Audio / Video · 13 Aug 2026, 9:31 pm
Suraksha Diagnostic Publishes Q1 FY27 Earnings Call Audio Recording Suraksha Diagnostic Limited has published the audio recording of its earnings call held on 13 Aug'26. The call discussed the unaudited standalone and consolidated financial results for the quarter ended 30 Jun'26, along with other business matters. The recording is now available on the company's official website, as per SEBI regulations.
Intimation of outcome of audio recording of Analyst/Institutional Investor/ Organizations meet-"Earning call" held today i.e. 13 Auust 2026
Audio / Video · 13 Aug 2026, 8:42 pm
Suraksha Diagnostic: Audio Recording of Q1FY27 Earnings Call Published Suraksha Diagnostic has published the audio recording of its earnings call held on 13 Aug'26. The call discussed the unaudited standalone and consolidated financial results for the quarter ended 30 Jun'26, along with other business matters. The recording is now available on the company's website for investors and analysts.
Investor Presentation for quarter 1 ended 30 June 2026
Investor Presentation · 12 Aug 2026, 11:59 pm
Suraksha Diagnostic: Strong Q1 FY27 Results Driven by Margin Expansion & Network Growth Suraksha Diagnostic reported strong Q1 FY27 results with revenue of INR 876.5 Mn (+21% YoY) and PAT of INR 128.5 Mn (+40% YoY). EBITDA margin expanded to 36.0% from 34.0% YoY, while PAT margin improved to 14.7%. Performance was driven by network expansion, with one hub and three spoke centres added, and robust growth in the high-margin genomics vertical, which grew 136% YoY to INR 13.7 Mn. The company also expanded into Jharkhand and improved profitability in new centres under two years old.
Press release in respect of unaudited ( Standalone and Consolidated) Financial Results for the quarter ended 30 June 2026
Press Release · 12 Aug 2026, 11:53 pm
Suraksha Diagnostics Reports Strong Q1 FY27 with 40% PAT Growth Suraksha Diagnostics reported strong Q1 FY27 results with total income growing 20.7% YoY to ₹887.33 million. EBITDA increased 27.9% YoY to ₹315.30 million, with the EBITDA margin expanding to 36.0% from 34.0%. Profit After Tax (PAT) surged 40.0% YoY to ₹128.45 million, improving the PAT margin to 14.7%. Performance was driven by a 12.1% increase in patient volumes and a 10.6% rise in average revenue per test. The company commissioned one hub and three spoke centres during the quarter ended 30 Jun'26.
Revised Record date if 15 September 2026 has been fixed
Others · 12 Aug 2026, 11:36 pm
Suraksha Diagnostic: Q1 FY27 Results, CFO Appointment, and Dividend Record Date For Q1 FY27 ended 30 Jun'26, Suraksha Diagnostic's consolidated revenue grew 20.7% YoY to ₹8,764.54 lakhs. Profit after tax rose 39.9% YoY to ₹1,284.54 lakhs. The Board appointed Mr. Dinesh Gupta as the new CFO, effective 24 Aug'26. A record date of 15 Sep'26 has been set for the FY26 dividend, pending shareholder approval at the AGM on 22 Sep'26. The company also provisioned ₹81.16 lakhs against a sub-judice dispute involving a step-down subsidiary in Meghalaya, impacting receivables of ₹393.67 lakhs.
Appointment of Chief Financial Officer of Mr. Dinesh Gupta
Change in Management · 12 Aug 2026, 11:31 pm
Suraksha Q1FY27 Results and Key Board Decisions Suraksha Diagnostic's Board approved Q1FY27 results and appointed Dinesh Gupta as Group CFO, effective 24 Aug'26. Consolidated revenue grew 20.7% YoY to ₹8,764.54 lakhs, with PAT up 40.0% YoY to ₹1,284.54 lakhs. Sequentially, PAT increased 108.5% QoQ from ₹615.92 lakhs. The Board also set the 21st AGM for 22 Sep'26 and fixed a record date of 15 Sep'26 for the FY26 dividend, subject to shareholder approval. A dispute in a step-down subsidiary has a potential impact of ₹393.67 lakhs.
Approved unaudited financial results ( Standalone and Consolidated) of the company for quarter ended 30 June 2026
Financial Result · 12 Aug 2026, 11:24 pm
Suraksha Q1FY27 Results, CFO Appointment, and Dividend Record Date Suraksha Diagnostic reported Q1FY27 consolidated net profit of ₹1,284.54 lakhs, a 39.9% YoY increase, on revenue of ₹8,764.54 lakhs, up 20.7% YoY. Sequentially, net profit grew 108.6% while revenue rose 7.7%. The board approved the results, appointed Mr. Dinesh Gupta as the new Group CFO effective 24 Aug'26, and set 15 Sep'26 as the record date for the FY26 dividend. The 21st AGM is scheduled for 22 Sep'26. Basic EPS for the quarter stood at ₹2.50 versus ₹1.80 YoY.
Outcome of Board meeting held today, i.e 12 August 2026
Outcome · 12 Aug 2026, 11:00 pm
Suraksha Diagnostic Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 8,765 (+20.7% YoY | +7.7% QoQ) ■ EBITDA: 3,044 (+28.2% YoY | +24.9% QoQ) ■ EBITDA Margin (%): 34.7 (+201 bps YoY | +480 bps QoQ) ■ PAT: 1,301 (+38.4% YoY | +107.1% QoQ) ■ EPS (INR): 2.50 (+38.9% YoY | +106.6% QoQ)
We wish to inform that the 21st Annual General Meeting of the Company which was scheduled to be held on Wednesday, 02 September 2026, stands postponed to a future date due to certain unavoidable ....
Annual General Meeting · 10 Aug 2026, 5:55 pm
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that there will be a Conference Call viz. ''Earnings Call'' ....
Intimation · 13 Aug 2026, 11:30 am
Suraksha Diagnostic to Host Q1 FY27 Earnings Call on 13th August Suraksha Diagnostic Limited will host a virtual earnings call for analysts and investors on 13 Aug'26 at 11:30 AM IST to discuss its unaudited financial results for the quarter ending 30 Jun'26. Key management, including the Chairman, CEO, and finance head, will participate. The discussion will be based on publicly available information, and the investor presentation will be accessible on the company's website. No unpublished price-sensitive information will be disclosed. The schedule is subject to change.
Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting ....
Intimation · 12 Aug 2026, 5:30 am
Suraksha Diagnostic Board Meeting to Approve Q1FY27 Results on 12 Aug'26 Suraksha Diagnostic Ltd. has scheduled a Board of Directors meeting for 12 Aug'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30 Jun'26. In connection with this, the trading window for designated persons, which closed on 01 Jul'26, will re-open 48 hours after the declaration of the financial results.
Resignation of Ms. Mamta Jain, Company Secretary & Compliance Officer and Key Managerial Personnel (KMP) of the Company.
Change in Management · 09 Jun 2026, 8:26 pm
Suraksha Diagnostic KMP and Company Secretary Resigns Suraksha Diagnostic Limited announced the resignation of Ms. Mamta Jain from her role as Company Secretary, Compliance Officer, and Key Managerial Personnel (KMP) on 09 Jun'26. Citing personal reasons for her departure, Ms. Jain has confirmed there are no other material reasons for the resignation. Her last working day with the company will be 15 Jul'26. This change in key management personnel is a notable event for corporate governance and compliance oversight at the firm.
Transcript of the Earning Call held on Friday, 22 May 2026 with respect to the Audited (Standalone and Consolidated) Financial results of the Company for the quarter and year ended March 31, 2026.
Transcript · 27 May 2026, 9:53 pm
Intimation of audio recording of Analysts/Institutional Investors/Organisations meet-''Earnings Call''
Audio / Video · 22 May 2026, 8:06 pm
Suraksha Diagnostic Publishes Q4 & FY26 Earnings Call Recording Suraksha Diagnostic has made the audio recording of its earnings call, held on 22 May'26, available on its website. The call discussed the audited standalone and consolidated financial results for the quarter and financial year ended 31 Mar'26. The disclosure complies with SEBI's LODR Regulations, 2015.
Press release in respect of audited (standalone and consolidated) financial results for the quarter and financial year ended 31 March 2026
Press Release · 22 May 2026, 2:32 am
Suraksha Diagnostic: Healthy Revenue Growth in FY26, Margin Pressure in Q4 Suraksha Diagnostic reported strong FY26 results with total income rising 22.5% YoY to ₹3,135.8 million, driven by a 22.0% increase in test volumes. Full-year EBITDA grew 15.8% to ₹985.6 million, though margins compressed to 31.8% from 33.8%. For Q4FY26, revenue increased 24.7% YoY to ₹822.0 million, and EBITDA grew 25.7% to ₹251.6 million. However, Q4 PAT declined 14.1% YoY to ₹61.6 million, with PAT margin falling to 7.6% from 11.0% in Q4FY25, reflecting investment in network expansion.